optical mapping
Bionano Genomics Lays off Nearly Half of Workforce, Lowers Full-Year 2024 Guidance
After the fourth round of layoffs, the optical genome mapping company will focus on its existing customers while placing less emphasis on new instrument sales.
Bionano Genomics Lowers Full-Year Guidance Due to Weak Sales in China
The optical genome mapping company's business also took a hit from its massive layoffs, which were part of ongoing cost-reduction measures.
Bionano Genomics Receives Nasdaq Delisting Warning Over Low Share Price
The San Diego-based optical genome mapping company has 180 calendar days to regain compliance with the minimum bid price requirement.
Bionano Genomics Upbeat on Further Clinical Adoption of Optical Genome Mapping With New CPT Code
Premium
The Category I CPT code paves the way for reimbursement of OGM-based clinical tests, though details on pricing and insurance coverage are still unclear.
Bionano Genomics Raises $17.9M in Debt Financing
The company said the private placement of senior convertible debentures will allow it to completely retire a previous convertible debt financing.
May 8, 2024
Bionano Genomics Q1 Revenues up 18 Percent
Nov 8, 2023
Bionano Genomics Q3 Revenues Grow 29 Percent
Oct 10, 2023
Bionano Genomics Initiates New Round of Layoffs
Aug 9, 2023
Bionano Genomics Books Record Revenues in Q2
May 10, 2023
May 2, 2023
Bionano Genomics Seeks Reverse Stock Split
Mar 9, 2023